Richard Bryce

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 2

Top Topics

Metastatic Breast Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Cynthia X Ma, Jingqin R Luo, Rachel A Freedman, Timothy J Pluard, Julie R Nangia, Janice Lu, Frances Valdez-Albini, Melody Cobleigh, Jason M Jones, Nancy U Lin, Eric P Winer, P Kelly Marcom, Shana Thomas, Jill Anderson, Brittney Haas, Leslie Bucheit, Richard Bryce, Alshad S Lalani, Lisa Anne Carey, Matthew P Goetz, Feng Gao, Gretchen Kimmick, Mark D Pegram, Matthew J Ellis, Ron Bose
The Phase II MutHER Study of Neratinib Alone and in Combination with Fulvestrant in HER2-Mutated, Non-amplified Metastatic Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (7) (2022)
Cristina Saura, Judit Matito, Mafalda Oliveira, Hans P M W Wildiers, Adam M Brufksy, Simon H Waters, Sara A Hurvitz, Beverly Moy, Sung-Bae Kim, William J Gradishar, Geraldo Silva Queiroz, Eduardo Henrique Cronemberger, Gerald J Wallweber, Judith Bebchuk, Kiana Keyvanjah, Alshad S Lalani, Richard Bryce, Ana Vivancos, Lisa D Eli, Suzette Delaloge
Biomarker Analysis of the Phase III NALA Study of Neratinib + Capecitabine versus Lapatinib + Capecitabine in Patients with Previously Treated Metastatic Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (21) (2021)